Cambridge Investment Research Advisors, Inc. Bio Techne Corp Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.9 Billion
  • Q4 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 2,923 shares of TECH stock, worth $189,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,923
Previous 2,511 16.41%
Holding current value
$189,761
Previous $201,000 4.98%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$66.37 - $78.17 $27,344 - $32,206
412 Added 16.41%
2,923 $211,000
Q3 2024

Oct 28, 2024
SELL
$70.96 - $82.35 $28,029 - $32,528
-395 Reduced 13.59%
2,511 $201,000
Q2 2024

Jul 26, 2024
SELL
$62.12 - $84.15 $512,986 - $694,910
-8,258 Reduced 73.97%
2,906 $208,000
Q1 2024

Apr 24, 2024
SELL
$65.98 - $77.09 $15,637 - $18,270
-237 Reduced 2.08%
11,164 $786,000
Q4 2023

Feb 09, 2024
SELL
$52.83 - $78.22 $23,192 - $34,338
-439 Reduced 3.71%
11,401 $880,000
Q3 2023

Oct 24, 2023
SELL
$67.52 - $89.42 $57,324 - $75,917
-849 Reduced 6.69%
11,840 $806,000
Q2 2023

Jul 13, 2023
BUY
$73.76 - $85.98 $144,274 - $168,176
1,956 Added 18.22%
12,689 $1.04 Million
Q1 2023

May 11, 2023
SELL
$71.62 - $86.62 $73,338 - $88,698
-1,024 Reduced 8.71%
10,733 $796,000
Q4 2022

Feb 08, 2023
BUY
$80.67 - $352.29 $858,248 - $3.75 Million
10,639 Added 951.61%
11,757 $974,000
Q3 2022

Oct 17, 2022
BUY
$282.54 - $391.85 $4,803 - $6,661
17 Added 1.54%
1,118 $317,000
Q2 2022

Jul 13, 2022
SELL
$322.67 - $449.65 $569,512 - $793,632
-1,765 Reduced 61.58%
1,101 $381,000
Q1 2022

May 12, 2022
SELL
$353.85 - $487.79 $288,741 - $398,036
-816 Reduced 22.16%
2,866 $1.24 Million
Q4 2021

Feb 03, 2022
BUY
$456.15 - $525.06 $223,969 - $257,804
491 Added 15.39%
3,682 $1.9 Million
Q3 2021

Nov 02, 2021
BUY
$444.87 - $538.88 $401,272 - $486,069
902 Added 39.41%
3,191 $1.55 Million
Q2 2021

Aug 10, 2021
SELL
$387.35 - $450.26 $326,148 - $379,118
-842 Reduced 26.89%
2,289 $1.03 Million
Q1 2021

May 07, 2021
BUY
$314.62 - $411.0 $9,753 - $12,741
31 Added 1.0%
3,131 $1.2 Million
Q4 2020

Feb 04, 2021
BUY
$246.9 - $321.87 $199,248 - $259,749
807 Added 35.19%
3,100 $984,000
Q3 2020

Oct 29, 2020
SELL
$232.22 - $282.96 $5.43 Million - $6.62 Million
-23,389 Reduced 91.07%
2,293 $568,000
Q2 2020

Jul 27, 2020
SELL
$185.43 - $279.56 $29,668 - $44,729
-160 Reduced 0.62%
25,682 $6.78 Million
Q1 2020

May 08, 2020
BUY
$161.17 - $221.51 $363,760 - $499,948
2,257 Added 9.57%
25,842 $4.9 Million
Q4 2019

Feb 04, 2020
BUY
$189.68 - $222.09 $3.8 Million - $4.45 Million
20,038 Added 564.93%
23,585 $5.18 Million
Q3 2019

Nov 06, 2019
BUY
$183.56 - $216.72 $550 - $650
3 Added 0.08%
3,547 $694,000
Q2 2019

Aug 15, 2019
BUY
$188.72 - $215.43 $11,511 - $13,141
61 Added 1.75%
3,544 $0
Q1 2019

May 08, 2019
SELL
$136.09 - $200.44 $22,318 - $32,872
-164 Reduced 4.5%
3,483 $0
Q4 2018

Feb 05, 2019
SELL
$132.75 - $203.8 $20,443 - $31,385
-154 Reduced 4.05%
3,647 $527,000
Q3 2018

Nov 02, 2018
BUY
$147.44 - $204.11 $24,475 - $33,882
166 Added 4.57%
3,801 $0
Q2 2018

Aug 10, 2018
SELL
$144.9 - $165.58 $18,837 - $21,525
-130 Reduced 3.45%
3,635 $0
Q4 2017

Feb 22, 2018
SELL
$121.17 - $134.75 $2,665 - $2,964
-22 Reduced 0.58%
3,765 $0
Q3 2017

Nov 07, 2017
SELL
$113.59 - $123.78 $23,285 - $25,374
-205 Reduced 5.14%
3,787 $458,000
Q2 2017

Aug 08, 2017
BUY
N/A
3,992
3,992 $469,000

Others Institutions Holding TECH

# of Institutions
615
Shares Held
156M
Call Options Held
161K
Put Options Held
12.7K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.55B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email